CCL23 has been found to be underexpressed in hepatoma cells, and this could lead to CCL23 deletion and reduced CCL23 inhibition via the ESR1/CCL23/CCR1/AKT regulatory axis in liver cancer progression (35). The gene discussed is ESR1; the disease is hepatocellular carcinoma.